# Hospital Universitari de Bellvitge

Organization · id `cardio:org-hospital-universitari-de-bellvitge` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ROR record 00epner96](<https://ror.org/00epner96>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.

## Technical summary

Sponsor class other. Matched to ROR record 00epner96 by an exact name.

## The registry's words

- Sponsor name: Hospital Universitari de Bellvitge
- Sponsor class: OTHER
- ROR name: Bellvitge University Hospital

## Connected pages

- Sponsors: SIRAKI 02 Posthoc Analysis. (`cardio:ct-nct06781294`)
- Sponsors: Oral Anticoagulation Versus Left Atrial Appendage Occlusion Added to Direct Oral Anticoagulation in Patients with Stroke Despite Oral (`cardio:ct-nct06869811`)
- Sponsors: ReDS-guided Decongestion Strategy in Patients Hospitalized for Heart Failure (`cardio:ct-nct07484009`)

## Provenance

Content hash: 66c7d04f13eb5d261e2bf737f727b1ee40e43cf05b33a92a04502933ce860e52
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
